Zolpidem Other names: Zolpidem tartrate

Chemical formula: C₁₉H₂₁N₃O  Molecular mass: 307.39 g/mol  PubChem compound: 5732

Therapeutic indications

Zolpidem is indicated for:

Insomnia

Population group: only adults (18 - 65 years old)

Zolpidem is indicated for the short-term treatment of insomnia in adults in situations where the insomnia is debilitating or is causing severe distress for the patient.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Insomnia

Population group: only elderly (65 years old or older)

Zolpidem is indicated for the short-term treatment of insomnia in adults in situations where the insomnia is debilitating or is causing severe distress for the patient.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Contraindications

Zolpidem is contraindicated in the following cases:

Obstructive sleep apnoea

Obstructive sleep apnea syndrome

Myasthenia gravis

Myasthenia gravis

Severe hepatic impairment

Hepatic failure stage IV

Acute and/or severe respiratory depression

Decreased respiratory function

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner

Related medicines

Summary of Product Characteristics (SPC) 2019: STILNOCT Coated tablet
Structured Product Labeling (SPL/PLR) 2020: AMBIEN Film-coated tablet
< Previous: Overview
Next: Precautions >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈